Your browser doesn't support javascript.
loading
Fludarabine and cyclophosphamide in combination with alemtuzumab in patients with primary high-risk, relapsed or refractory chronic lymphocytic leukemia.
Elter, T; James, R; Busch, R; Winkler, D; Ritgen, M; Böttcher, S; Kahl, C; Gassmann, W; Stauch, M; Hasan, I; Staib, P; Fischer, K; Fink, A-M; Bahlo, J; Bühler, A; Döhner, H; Wendtner, C-M; Stilgenbauer, S; Engert, A; Hallek, M.
Leukemia ; 26(12): 2549-52, 2012 Dec.
Article in En | MEDLINE | ID: mdl-22584787
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell / Antineoplastic Combined Chemotherapy Protocols / Salvage Therapy / Drug Resistance, Neoplasm / Neoplasm Recurrence, Local Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2012 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell / Antineoplastic Combined Chemotherapy Protocols / Salvage Therapy / Drug Resistance, Neoplasm / Neoplasm Recurrence, Local Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2012 Document type: Article